T3 · Product exporter position
See where Israel stands in medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.
Latest exports
$1.9MLatest observed lane totalDestination markets
6Reported active marketsThree-year growth
-37.3%Annualized changeDestination HHI
632Destination concentrationWeighted share
12.8%Reported market positionExporter evidence
Reported exporter totals and calculated indicators for HS 300339. Values retain their observed coverage period.
Exporter scale
Market position
Competitiveness
| Measure | Value | What it describes |
|---|---|---|
| Exporter | Israel | Country represented by this profile |
| Latest observed exports | $1.9M | Sum of latest observed destination-lane values |
| Current 2024 exports | $218.6K | Common-year comparison where reported |
| Three-year growth | -37.3% | Annualized change in exporter totals |
| Five-year growth | -37.7% | Annualized change in exporter totals |
| Leading destination | SWE | Destination with the largest observed export value |
| Leading destination share | 10.7% | Share of observed exporter totals |
| Destination concentration | 632 | HHI across destination markets |
| Weighted share change | +5.2 pp | Value-weighted latest change in market share |
| Limited-history lanes | 61% | Share of lanes with shorter history |
Destination markets
Leading destination observations ranked by reported export value, with market position and access context.
Destination observations are not available.
Price intelligence
Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.
Germany: $6.3M / ton.
Denmark: $666.7 / ton.
$174.8K / ton across reported markets.
Export trend
Annual observations for Israel and HS 300339 where available.
| Year | Exports | Year-on-year change | Active destinations |
|---|---|---|---|
| 2010 | $5.9M | +1,497.9% | 6 |
| 2011 | $40.3M | +587.2% | 12 |
| 2012 | $3.3M | -91.8% | 12 |
| 2013 | $4.4M | +31.7% | 13 |
| 2014 | $1.6M | -62.8% | 9 |
| 2015 | $732.5K | -55% | 11 |
| 2016 | $2.1M | +181.3% | 12 |
| 2017 | $8.3M | +302.3% | 10 |
| 2018 | $11.8M | +41.8% | 10 |
| 2019 | $2.3M | -80.1% | 10 |
| 2020 | $1.3M | -45.1% | 8 |
| 2021 | $885.5K | -31% | 14 |
| 2022 | $434.3K | -50.9% | 8 |
| 2023 | $2.4M | +441.5% | 8 |
| 2024 | $218.6K | -90.7% | 6 |
Exporter context
The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300339.
Israel has reported exports of $68.3B and a trade balance of -$17.9B in 2024.
Available structural indicators include 38.8% trade openness, 21.4% investment, and 270 active trade partners.
Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.
Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.
Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.
Frequently asked questions
Quick answers based on the figures and coverage shown on this page.
Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.
The destination table ranks reported markets by the latest observed export value.
No. It summarizes reported trade value and quantity observations converted to unit values.
Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.
